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1. Alignment of TrpB homologs 
 
0B2 MUTATIONS                                   L    G  
Pyrococcus furiosus     -------------MWFGEFGGQYVPETLIEPLKELEKAYKRFKDDEEFNRQLNYYLKTWA 47 
Archaeoglobus fulgidus  MRCWLENLSGGRKMKFGEFGGRFVPEVLIPPLEELEKAYDRFKDDEEFKARLEYYLKSYA 60 
Thermotoga maritima     -----------MKGYFGPYGGQYVPEILMPALEELEAAYEEIMKDESFWKEFNDLLRDYA 49 
Escherichia coli        -------MTTLLNPYFGEFGGMYVPQILMPALRQLEEAFVSAQKDPEFQAQFNDLLKNYA 53 
                                     ** :** :**: *:  *.:** *:    .* .*  .::  *: :* 
0B2 MUTATIONS                               V 
Pyrococcus furiosus     GRPTPLYYAKRLTEKIGGAKIYLKREDLVHGGAHKTNNAIGQALLAKFMGKTRLIAETGA 107 
Archaeoglobus fulgidus  GRPTPLYFAENLSREL-GVKIYLKREDLLHGGAHKINNTIGQALLAKFMGKKRVIAETGA 119 
Thermotoga maritima     GRPTPLYFARRLSEKY-GARIYLKREDLLHTGAHKINNAIGQVLLAKKMGKTRIIAETGA 108 
Escherichia coli        GRPTALTKCQNITAGT-NTTLYLKREDLLHGGAHKTNQVLGQALLAKRMGKTEIIAETGA 112 
                        **** *  ...::     . :*******:* **** *:.:**.**** ***..:****** 
0B2 MUTATIONS  
Pyrococcus furiosus     GQHGVATAMAGALLGMKVDIYMGAEDVERQKMNVFRMKLLGANVIPVNSGSRTLKDAINE 167 
Archaeoglobus fulgidus  GQHGVATAMAAALLGLEAEIYMGAEDYERQKMNVFRMELLGAKVTAVESGSRTLKDAINE 179 
Thermotoga maritima     GQHGVATATAAALFGMECVIYMGEEDTIRQKPNVERMKLLGAKVVPVKSGSRTLKDAINE 168 
Escherichia coli        GQHGVASALASALLGLKCRIYMGAKDVERQSPNVFRMRLMGAEVIPVHSGSATLKDACNE 172 
                        ******:* *.**:*::  **** :*  **. ** **.*:**:*  *.*** ***** ** 
0B2 MUTATIONS                          
Pyrococcus furiosus     ALRDWVATFEYTHYLIGSVVGPHPYPTIVRDFQSVIGREAKAQILEAEGQLPDVIVACVG 227 
Archaeoglobus fulgidus  ALRDWVESFEHTHYLIGSVVGPHPFPTIVRDFQAVIGKEARRQIIEAEGGMPDAIIACVG 239 
Thermotoga maritima     ALRDWITNLQTTYYVIGSVVGPHPYPIIVRNFQKVIGEETKKQILEKEGRLPDYIVACVG 228 
Escherichia coli        ALRDWSGSYETAHYMLGTAAGPHPYPTIVREFQRMIGEETKAQILEREGRLPDAVIACVG 232 
                        *****  . : ::*::*:..****:* ***:** :**.*:: **:* ** :** ::**** 
0B2 MUTATIONS                                                         S          
Pyrococcus furiosus     GGSNAMGIFYPFVNDKKVKLVGVEAGGKGLESGKHSASLNAGQVGVFHGMLSYFLQDEEG 287 
Archaeoglobus fulgidus  GGSNAMGIFHPFLND-DVRLIGVEAGGEGIESGRHSASLTAGSKGVLHGMLSYFLQDEEG 298 
Thermotoga maritima     GGSNAAGIFYPFIDS-GVKLIGVEAGGEGLETGKHAASLLKGKIGYLHGSKTFVLQDDWG 287 
Escherichia coli        GGSNAIGMFADFINETNVGLIGVEPGGHGIETGEHGAPLKHGRVGIYFGMKAPMMQTEDG 292 
                        ***** *:*  *::.  * *:*** **.*:*:*.*.* *  *  *  .*  : .:* : * 
0B2 MUTATIONS               S                            A 
Pyrococcus furiosus     QIKPTHSIAPGLDYPGVGPEHAYLKKIQRAEYVTVTDEEALKAFHELSRTEGIIPALESA 347 
Archaeoglobus fulgidus  MMLDTHSVSAGLDYPGVGPEHAYLKETGRCEYVTVNDEEALRAFKTLSKLEGIIPALESA 358 
Thermotoga maritima     QVQVTHSVSAGLDYSGVGPEHAYWRETGKVLYDAVTDEEALDAFIELSRLEGIIPALESS 347 
Escherichia coli        QIEESYSISAGLDFPSVGPQHAYLNSTGRADYVSITDDEALEAFKTLCLHEGIIPALESS 352 
                         :  ::*:: ***: .***:*** ..  :  * ::.*:*** **  *.  *********: 
0B2 MUTATIONS                        
Pyrococcus furiosus     HAVAYAMKLAKE-MSRDEIIIVNLSGRGDKDLDIVLKVSGNV---- 388 
Archaeoglobus fulgidus  HAIAYAMKMAEE-MQRDDVLVVNLSGRGDKDMDIVRRRLA------ 397 
Thermotoga maritima     HALAYLKKIN----IKGKVVVVNLSGRGDKDLESVLNHPYVRERIR 389 
Escherichia coli        HALAHALKMMRENPDKEQLLVVNLSGRGDKDIFTVHDILKARGEI- 397 
                        **:*:  *:      : .:::**********:  * 
 
Figure S1. Multiple sequence alignment of Pyrococcus furiosus, Archaeoglobus fulgidus, Thermotoga maritima, 
and Escherichia coli TrpB homologs. The mutated residues in PfTrpB0B2 are shown in red in the first line. Active 
site residues (distance to active site < 3.2Å) are colored in blue whereas those involved in proton transfer during 
catalysis are colored in green. Symbols under sequences signify: (*)identical residues, (:)residues of equal nature, 
and (.)similar residues.
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Figure S2. Structural alignment of PfTrpB (PDB entry 5DVZ) and EcTrpB (PDB entry 2DH5). The residues mutated in PfTrpB0B2 are shown in sticks. Windows 
show the region surrounding each labeled mutation
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2. Characterization of TmTrpS, TmTrpB, and variants with 0B2 mutations 
 
Figure S3. kcat values of TmTrpS and all studied variants of TmTrpB. The mutations are labeled below each bar. 
Measurements were performed using the procedure described in section 5.4. The standard error of the fit is <20%.
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Figure S4. UV-vis spectra of TmTrpS and all TmTrpB studied variants. The mutation is labeled below each 
graph. Spectra with the holo-protein are represented in black solid lines. Addition of Ser (colored lines) results 
in a spectroscopic shift that reflects the steady state distribution of E(Aex1) and E(A-A) intermediates with 
λmax = 428 nm and 350 nm, respectively.  To facilitate analysis, lines are colored according to whether the 
predominant peak comes from E(Aex1), red lines, or E(A-A), blue lines.   
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3. Libraries of EcTrpB variants 
 
 
 
Figure S5. a) Activity profile of a site-saturation library at residue S297 in EcTrpB. b) Activity profile of a 
recombination library of the 0B2 mutations (see methods for details). 
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4. Analysis of PfTrpBM144T N166D and homologous variants 
	 	
Figure S6. Frequency of residues present at positions 144 and 166 (according to PfTrpB numeration) across 
different species. 
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Figure S7. UV-vis absorption spectra of the double mutants of (a) P. furiosus, (b) A. fulgidus, (c) T. maritima, and 
(d) E. coli. Spectra with the holo-protein are represented in black solid lines. Similar to Figure S4, recorded spectra 
after addition of L-serine are represented in blue solid lines when the predominant absorbance peak belongs to E(A-
A), and red when it belongs to E(Aex1). 
 
 
 
 
 
Figure S8. Percent conversion to 5-bromotryptophan attained by several activated TrpB variants. Reactions with Pf 
and Tm variants were done at 75 °C, whereas reactions with Af and Ec variants were done at 37 °C. Reaction 
conditions are identical to those reported for 5-bromoindole in Section 6.2, except the reactions were run for 12 
hours. Conversion was determined by LCMS analysis. 
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5. Procedures for enzyme expression and characterization  
5.1 Cloning, expression, and purification of TrpB homologs 
The genes encoding AfTrpB (UNIPROT ID O28672), TmTrpB (UNIPROT ID P50909), and EcTrpB (UNIPROT 
ID P0A879) were obtained from Integrated DNA Technologies (IDT, San Diego, USA) as gBlocks and cloned into 
pET22(b)+ using Gibson assembly.[1] Protein expression of the homologs was carried out in Escherichia coli BL21 
E. cloni Express cells (Lucigen) by inoculating 10 mL Terrific Broth containing 100 µg/mL ampicillin (TBamp) with 
a single colony and incubating this pre-culture over night at 37 °C and 250 rpm. The overnight cultures were used to 
inoculate 500-mL TBamp expression cultures to an OD600 of 0.1. After shaking at 250 rpm and 37 °C for ~3 h, the 
cultures were chilled on ice for 20 min and then induced with IPTG to a final concentration of 1 mM. Expression of 
the homologs took place at 250 rpm and 20 °C for another 20 h. After centrifugation, the cell pellets were frozen and 
stored at –20 °C until further use.  
For protein purification, cells were thawed and then resuspended in 50 mM potassium phosphate buffer (KPi), pH 
8.0, containing 20 mM imidazole, 100 mM NaCl (buffer A), and 200 µM PLP. Lysis was performed with BugBuster 
(Novagen) for 15 min at 37 °C. After removal of the cell debris by centrifugation, TmTrpB (but not AfTrpB or 
EcTrpB) lysate was then incubated at 75 °C for 10 min and was subjected to another centrifugation step. Afterwards, 
purification was done using a 1-mL histrap HP column with an AKTA purifier FPLC system (GE Healthcare) and a 
linear gradient from buffer A to buffer B (50 mM KPi, pH 8.0, 500 mM imidazole, and 100 mM NaCl). Proteins 
eluted at approximately 140 mM imidazole. Purified proteins were dialyzed into 50 mM KPi, pH 8.0, flash-frozen in 
liquid N2, and stored at –80 °C until further use.  
The TmTrpA and AfTrpA genes were also obtained from IDT as gBlocks and cloned into pET28 via Gibson 
assembly using restriction enzymes NcoI and XhoI on the backbone. To generate the complexes TmTrpS or AfTrpS, 
both the A and the B subunit of each homolog were independently expressed and purified as described above. 
Afterwards, purified proteins were mixed using a final ratio of 1:3 (TrpB:TrpA).  
Protein concentrations were determined via the Bradford assay (Bio-Rad).  
 
5.2 Library construction 
For TmTrpB, a recombination library of mutations P14L, P19G, I69V, L274S, and T292S was constructed using 
site-directed mutagenesis by overlap extension (SOE) PCR.[2] In this library, we allowed both the native residue and 
the mutation at each of the sites. After generating the fragments via PCR, they were DpnI digested, gel purified, and 
used as template for the subsequent assembly PCR using the flanking primers only. The assembly PCR product was 
cloned via Gibson into pET22(b)+ between restriction sites NdeI and XhoI.  
For the EcTrpB recombination library, the process was analogous and the recombined mutations were P18G, 
P23G, L73V, Y279S, and S326A. For the EcTrpB site-saturation library at position S297, three primers were 
designed containing codons NDT (encoding for Ile, Asn, Ser, Gly, Asp, Val, Arg, His, Leu, Phe, Tyr, and Cys), 
VHG (encoding for Met, Thr, Lys, Glu, Ala, Val, Gln, Pro, and Leu), and TGG (Trp), respectively, thereby 
including all 20 natural amino acids. These three primers were mixed in a ratio 12:9:1 according to the 22-codon-
trick.[3] Then, the SOE PCR was performed as described above.  
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5.3 Library screening 
For TmTrpB library screening, BL21 E. cloni Express cells carrying TmTrpB wild-type and variant plasmids were 
grown in 96-well deep-well plates in 300 µL/well TBamp at 37 °C and 80% humidity with shaking at 250 rpm 
overnight. Then, 20 µL of the overnight cultures were transferred to 630 µL TBamp and allowed to grow at 37 °C and 
80% humidity with shaking at 250 rpm for 3 h. After chilling the cultures on ice for 20 min, ITPG was added to a 
final concentration of 1 mM. Expression was allowed to continue for another 20 h at 20 °C with shaking at 250 rpm. 
Cells were then centrifuged at 4,000g for 10 min and frozen at –20 °C for a minimum of 24 h. For screening, cells 
were thawed at room temperature and then subjected to lysis by the addition of 400 µL/ well of 200 mM KPi buffer, 
pH 8.0, with 1 mg/mL lysozyme and 0.05 mg/mL DNaseI for 1 h at 37 °C. After centrifugation at 5,000g for 20 
min, a 160-µL aliquot of the lysate was transferred into PCR plates (USA Scientific, Ocala, USA), heat-treated for 1 
h at 75 °C, and then spun again at 1,000g and 4 °C for 30 min. After the transfer of 40 µL of the lysates to a fresh 
96-well deep well plate, 160 µL of assay buffer (200 mM phosphate buffer, 200 m M indole, 100 mM L-serine, pH 
8.0) were added. Reaction was allowed for 15 min at 75 °C and quenched by addition of 200 µL of CH3CN. The 
plates were then centrifuged for 10 min at 4,000g, and 100 µL of the supernatant were transferred to a 96-well plate 
for HPLC analysis (4.6 × 50 mm C-18 silica column with acetonitrile/water: 0% acetonitrile for 1 min, 0% to 100% 
over 5 min, 100% for 1 min). The conversion was approximated by comparing the integrations of the tryptophan 
signal (2.4 min) and the indole signal (4.4 min) at 280 nm.  
For screening of the EcTrpB library, expression was done analogously to the TmTrpB library; however, we 
omitted the final freezing step at –20 °C. Instead, once the supernatant was discarded, the pelleted cells were 
resuspended in 400 µL/well of 200 mM KPi, pH 8, and 40 µL were transferred to a fresh 96-well deep-well plate 
containing 160 µL of assay buffer (200 mM phosphate buffer, 8 mM indole, 100 mM L-serine, pH 8). After a 1-h 
reaction at 37 °C, 300 µL of CH3CN (83% v/v) were added to stop the reaction. Plates were centrifuged for 10 min 
at 4,000g. Subsequently, 100 µL of the supernatant were transferred to a 96-well plate for HPLC, where the ratio 
between indole and tryptophan was measured as described above for the TmTrpB library.  
 
5.4 Kinetics and spectroscopy 
For all TrpB and TrpS enzymes kcat values were measured by recording the change of absorption at 290 nm, using 
Δε290 = 1.89 mM–1 cm–1 as determined elsewhere.[4] Measurements were made in a UV1800 Shimadzu 
spectrophotometer at 60 °C for AfTrpB, 75 °C for TmTrpB, and 37 °C for EcTrpB over 90 seconds. The assay buffer 
was 200 mM KPi, pH 8, with 40 µM PLP. Michaelis-Menten constants (KM) for indole were determined using a 
concentration range from 400–6.25 µM indole with a fixed concentration of L-serine of 300 mM. Data fitting was 
done with the SigmaPlot2000 software. 
Spectra were recorded on the UV1800 Shimadzu spectrophotometer using a wavelength range from 250 to 550 
nm. The buffer contained 200 mM KPi, pH 8.0, and the protein concentration was 20 µM. Measurement 
temperatures were the same as used in the kinetics experiments described above. After a 3-min incubation at the 
corresponding temperature, the spectrum of the holo-protein was recorded. Then, a 20-mM solution of L-serine was 
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added and immediately spectra were measured to limit the deamination of L-serine, a side reaction that gives rise to 
pyruvate,[5] which absorbs at 320 nm. 
 
Table S1. Kinetic parameters for all studied enzymes.[a] 
Entry Enzyme 
kcat 
(s–1) 
KM 
(μM indole) 
 
Entry Enzyme 
kcat 
(s–1) 
KM 
(μM indole) 
1 PfTrpBWT 0.31 ± 0.02 77 ± 12  8 TmTrpB
T292S 5.8 ± 0.2 25 ± 4 
2 PfTrpB0B2 2.9 ± 0.2 9 ± 2  9 TmTrpS 2.2 ± 0.1 44 ± 7 
3 AfTrpBWT 0.074 ± 0.001 12 ± 1  10 PfTrpB
M144T N166D 0.83 ± 0.03 42	± 5 
4 AfTrpB0B2 0.51 ± 0.01 4.8 ± 0.6  11 EcTrpB
M149T N171D 0.34 ± 0.01 18	± 3 
5 TmTrpBWT 1.28 ± 0.07 33 ± 7  12 TmTrpB
M145T N167D 3.3 ± 0.1 32	± 4 
6 TmTrpB0B2 0.11 ± 0.02 72 ± 4  13 AfTrpB
M156T N178D 0.34 ± 0.01 11	± 2 
7 TmTrpBtriple 9.8 ± 0.3 26 ± 3  14 EcTrpB
WT 0.16 ± 0.01 19	± 1 
[a] Measurement temperatures were 75 °C for Pf and TmTrpB, 65 °C for AfTrpB, and 37 °C for EcTrpB. 
 
6. Synthesis and characterization of tryptophan derivatives 
6.1 General information for biocatalytic reactions  
Proton NMR spectra were recorded on a Varian 500 MHz spectrometer. Proton chemical shifts are reported in 
ppm (δ) relative to tetramethylsilane and calibrated using the residual solvent resonance (D2O, δ 4.79 ppm). Data are 
reported as follows: chemical shift (multiplicity [singlet (s), doublet (d), doublet of doublets (dd), doublet of 
doublets of doublets (ddd), doublet of triplets (dt), triplet (t), multiplet (m)], coupling constants [Hz], integration).  
Carbon NMR spectra were recorded with complete proton decoupling on a Varian 500 MHz (125 MHz) 
spectrometer or Bruker 400 MHz (100 MHz) spectrometer equipped with a cryo probe. Carbon chemical shifts are 
reported in ppm relative to tetramethylsilane and calibrated using the residual solvent proton resonance (vide supra). 
All NMR spectra were recorded at ambient temperature (about 25 °C). Reversed-phase chromatography was 
performed on a Biotage Isolera One purification system, using C-18 silica as the stationary phase, with methanol as 
the strong solvent and water as the weak solvent. The gradient of the eluent (Ñ) is given as % strong solvent/column 
volume (CV). Liquid chromatography/mass spectrometry (LCMS) was performed on an Agilent 1290 UPLC-LCMS 
equipped with a 2.1 × 50 mm C-18 silica column, using acetonitrile as the strong solvent and 0.1% (v/v) acetic 
acid/water as the weak solvent. The samples were ionized by electrospray ionization (ESI). High-resolution mass 
spectrometry (HRMS) was conducted with a JMS-600H (JEOL) instrument, with samples ionized by fast atom 
bombardment (FAB), or by time-of-flight mass spectroscopy with a Waters LCT Premier XE with UPLC, with 
samples ionized by ESI. All starting materials were purchased from commercial sources and used without further 
purification. The optical purity of the products was determined by derivatization with N-(5-fluoro-2,4-
dinitrophenyl)alanamide (FDNP-alanamide)[6] as described below.  
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6.2 Reactions to compare relative rates 
The reactions using the 5-chloro, 5-bromo, 5-cyano, 5-hydroxy, 5-methyl, and 5-methoxy substrates used the 
following procedure: an HPLC vial was charged with 10 µL of a 200 mM stock solution of the indole derivative in 
DMSO (10 mM final concentration), followed by 174 µL of a stock solution formed by mixing 1730 µL of aqueous 
potassium phosphate buffer (200 mM phosphate, pH 8.0), 10 µL of aqueous L-serine (2 M, 10 mM final 
concentration), and 2.7 µL of aqueous PLP (1.5 mM, 2 µM final concentration). The vials were sealed, then placed 
in a heating block that had been equilibrated to 75 °C. After 1 minute, the enzyme (either TmTrpBM145T N167D or 
PfTrpB0B2) was added as 16 µL of a 5 µM solution in aqueous phosphate buffer (200 mM phosphate, pH 8.0). The 
reactions were kept at 75 °C for 15 minutes, then cooled in ice. After the reactions were diluted by the addition of 
800 µL of 1:1 acetonitrile/water, they were subjected to centrifugation at 20,000g for 10 min and at 4 °C. The 
supernatants were analyzed by LCMS (vide infra). All reactions were run in duplicate. 
The reactions using the 5-nitro, 5-borono, and 5-formyl substrates were tested using an identical procedure, except 
for the following modifications: after the indole derivative was added, the vial was charged with 182 µL of a stock 
solution formed by mixing 1,800 µL of aqueous potassium phosphate buffer (200 mM phosphate, pH 8.0), 10 µL of 
aqueous L-serine (2 M, 10 mM final concentration), and 13 µL of aqueous PLP (1.5 mM, 10 µM final 
concentration). The enzyme (either TmTrpBM145T N167D or PfTrpB0B2) was added as 8 µL of a 50 µM solution in 
aqueous phosphate buffer (200 mM phosphate, pH 8.0). 
 
6.3 Estimation of relative rates 
All reaction mixtures, except those of 6-hydroxyindole, were analyzed by LCMS (1 µL injection volume) using a 
solvent gradient that ranged from 5% to 95% strong solvent over 4 minutes, with a flow rate of 1.0 mL/min. The 
reaction mixtures generated from 6-hydroxyindole as a substrate were analyzed by a different solvent gradient that 
ranged from 0% to 20% strong solvent over 4 minutes, also with a flow rate of 1.0 mL/min. The total ion count 
(TIC) was then filtered for the [M+H]+ of the expected product. The filtered TICs were integrated and the ratio of 
the integrations obtained with TmTrpBM145T N167D to those obtained with PfTrpB0B2 was taken as an approximation of 
the relative initial rates for both enzymes. 
 
Table S2. Comparison of relative rates. 
 Integration of TIC 
 
 Integration of TIC 
X PfTrpB0B2 TmTrpBM145T N167D X PfTrpB0B2 TmTrpBM145T N167D 
Cl (4.0 ± 0.2) × 105 (1.2 ± 0.1) × 106  B(OH)2[a] (2.37 ± 0.02) × 102 (4.28 ± 0.09) × 102 
Br (1.78 ± 0.03) × 104 (1.00 ± 0.04) × 105  OH (4.09 ± 0.09) × 105 (5.9 ± 0.2) × 105 
NO2 (4.2 ± 0.3) × 104 (3.1 ± 0.1) × 105  CH3 (5.7 ± 0.2) × 105 (8.2 ± 0.8) × 105 
CN (7 ± 1) × 103 (3.07 ± 0.04) × 104  OCH3 (2.33 ± 0.03) × 105 (3.52 ± 0.09) × 105 
CHO (1.37 ± 0.01) × 105 (2.57 ± 0.08) × 105     
[a] Integration of absorption at 280 nm. 
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6.4 Preparative reactions for product characterization 
General procedure: the indole derivative was weighed directly into a 20-mL reaction vial, then dissolved in 
DMSO (5% of final reaction volume). Next, L-serine (1.2 or 2 equiv) was added as a 2 M aqueous solution, 
followed by PLP (5 equiv with respect to enzyme), which was added as a 15 mM aqueous solution. Finally, the 
reaction mixture was diluted with the appropriate quantity (vide infra) of aqueous potassium phosphate buffer (200 
mM phosphate, pH 8). The vial was sealed, then placed in a water bath that had been equilibrated to 75 °C. After 1 
min, the enzyme TmTrpBM145T N167D (0.01 or 0.02 mol %) was added as a 200-µM solution in aqueous potassium 
phosphate buffer (50 mM phosphate, pH 8). The reaction was kept at 75 °C for the indicated reaction time (2 or 12 
h), then cooled in ice.  
The reaction mixture was acidified by the addition of conc. aq. HCl (200 µL), then washed with ethyl acetate (50 
mL). The organic phase was washed with 0.1 M aq. HCl (2 × 20 mL), then the combined aqueous layers were 
concentrated in vacuo. The residue was re-dissolved in water, then loaded onto a C-18 column (30 g) that had been 
equilibrated to 1% methanol/water. The column was washed with five column volumes (CV) of 1% methanol/water 
to remove residual salts and DMSO. Finally, the product was eluted with a gradient that went from 1% to 100% 
methanol/water over 10 CV. The fractions containing product were concentrated in vacuo. As the free base, the 
products had poor solubility in most solvents. Thus, they were re-dissolved in 0.1 M aq. HCl. The resulting solutions 
were partially concentrated on a rotary evaporator, then frozen and concentrated to dryness on a lyophilizer. The 
products were obtained as the hydrochloride salts, which tended to have good solubility in water. 
 
6.5 Determination of optical purity  
FDNP-alanamide was used as a solution in acetone (33 mM). In a 2-mL vial, the amino acid (0.50 µmol) was 
dissolved in 1 M aq. NaHCO3 (140 µL). FDNP-alanamide (30 µL, 1 µmol) was added, then the vial was placed in an 
incubator at 37 °C. After 1 h, the reaction mixture was allowed to cool to room temperature, then diluted with 1:1 
water/acetonitrile (550 µL). The resulting solution was analyzed directly by LCMS (5 to 95% acetonitrile over 10 
minutes, monitoring at 330 nm or using the total ion count filtered for the expected mass. Each amino acid was 
derivatized with both racemic and enantiopure FDNP-alanamide for comparison. Since the products of 
derivatization are diastereomeric, they may have different absorption properties and ionization efficiencies. Indeed, 
the racemic controls indicate that, in all cases, the derivatized minor enantiomer produces stronger signal than the 
derivatized major enantiomer. Thus, this analysis represents a lower limit on the enantiopurity of the tryptophan 
derivatives, all of which had >98% ee. Absolute stereochemistry was inferred by analogy to L-tryptophan. 
 
5-chlorotryptophan (Table 4, entry 1). The reaction was performed with 75.8 mg of 5-chloroindole 
(500 µM), 2 equiv of L-Ser, and 0.01 mol % of enzyme. The starting materials were dissolved in 500 
µL DMSO and 8838 µL of potassium phosphate buffer, for a final reaction volume of about 10 mL. 
The reaction was heated for 12 hours, then processed as described above to afford 5-chlorotryptophan 
hydrochloride as a white solid (128 mg, 93% yield), corresponding to 9300 turnovers. 
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1H NMR (500 MHz, D2O) δ 7.63 (d, J = 2.0 Hz, 1H), 7.43 (d, J = 8.7 Hz, 1H), 7.31 (s, 1H), 7.20 (dd, J = 8.7, 2.0 
Hz, 1H), 4.32 (dd, J = 7.1, 5.3 Hz, 1H), 3.40 (ABX, JAX = 7.2 Hz, JBX = 5.4 Hz, JAB = 15.5 Hz, νAB = 33.9 Hz, 2H). 
13C NMR (100 MHz, D2O) δ 171.9, 134.7, 127.6, 126.7, 124.6, 122.1, 117.5, 113.1, 106.1, 53.3, 25.7. HRMS 
(FAB) (m/z) for [M+H]+ C11H12ClN2O2 requires 239.0587, observed 239.0596. 
	
 
5-bromotryptophan (Table 4, entry 2). The reaction was performed with 19.6 mg (100 µM) of 5-
bromoindole derivative, 2 equiv of L-Ser, and 0.02 mol % of enzyme. The starting materials were 
dissolved in 500 µL DMSO and 9.3 mL of potassium phosphate buffer, for a final reaction volume of 
about 10 mL. The reaction was heated for 12 hours, then processed as described above to afford 5-
bromotryptophan hydrochloride as a white solid (28 mg, 88% yield), corresponding to 4400 turnovers. 1H NMR 
(500 MHz, D2O) δ 7.75 (s, 1H), 7.36 (d, J = 8.6 Hz, 1H), 7.30 (d, J = 8.7 Hz, 1H), 7.27 (s, 1H), 4.30 (dd, J = 6.7, 5.8 
Hz, 1H), 3.36 (ABX, JAX = 7.2 Hz, JBX = 5.3 Hz, JAB = 15.4 Hz, νAB = 34.9 Hz, 2H). 13C NMR (100 MHz, D2O) δ 
171.8, 135.0, 128.2, 126.6, 124.7, 120.6, 113.6, 112.1, 106.0, 53.2, 25.6. HRMS (FAB) (m/z) for [M+H]+ 
C11H12BrN2O2 requires 283.0082, observed 283.0094. 
	
 
Procedure for Table 4, entries 3–5. The reaction was performed with 250 µM of indole derivative, 2 equiv of L-
Ser, and 0.02 mol % of enzyme. The starting materials were dissolved in 1250 µL DMSO and 23 mL of potassium 
phosphate buffer, for a final reaction volume of about 25 mL. The reaction was heated for 12 hours, then processed 
as described above to afford the tryptophan derivative as the hydrochloride salt. 
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Signal 1: DAD1 A, Sig=330,8 Ref=off
Peak RetTime Type Width Area Height Area
# [min] [min] [mAU*s] [mAU] %
----|-------|----|-------|----------|----------|--------|
1 3.951 BV 0.0539 4127.70850 1098.07617 98.9798
2 4.333 VB 0.0572 42.54555 10.97573 1.0202
Signal 1: DAD1 A, Sig=330,8 Ref=off
Peak RetTime Type Width Area Height Area
# [min] [min] [mAU*s] [mAU] %
----|-------|----|-------|----------|----------|--------|
1 3.962 BV 0.0499 2054.89600 601.42572 44.0578
2 4.273 VV 0.0558 2609.19141 680.12585 55.9422
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Signal 1: DAD1 A, Sig=330,8 Ref=off
Peak RetTime Type Width Area Height Area
# [min] [min] [mAU*s] [mAU] %
----|-------|----|-------|----------|----------|--------|
1 4.031 BV 0.0557 3465.82910 905.23956 98.9416
2 4.442 VB 0.0389 37.07407 13.98622 1.0584
Signal 1: DAD1 A, Sig=330,8 Ref=off
Peak RetTime Type Width Area Height Area
# [min] [min] [mAU*s] [mAU] %
----|-------|----|-------|----------|----------|--------|
1 4.037 BV 0.0504 1753.85291 506.23032 42.9551
2 4.345 VV 0.0566 2329.13696 595.47882 57.0449
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5-nitrotryptophan (Table 4, entry 3). Yellow solid (18 mg, 25% yield), corresponding to 1250 
turnovers. 1H NMR (500 MHz, D2O) δ 8.33 (d, J = 2.2 Hz, 1H), 7.87 (dd, J = 9.0, 2.3 Hz, 1H), 7.35 
(d, J = 9.2 Hz, 1H), 7.33 (s, 1H), 4.28 (dd, J = 6.9, 5.6 Hz, 1H), 3.36 (ABX, JAX = 6.9 Hz, JBX = 5.5 
Hz, JAB = 15.5 Hz, νAB = 25.2 Hz, 2H). 13C NMR (100 MHz, D2O) δ 172.0, 140.5, 139.7, 128.4, 
125.8, 117.4, 115.76, 111.8, 109.2, 53.4, 25.5. HRMS (FAB) (m/z) for [M+H]+ C11H12N3O4 requires 250.0828, 
observed 250.0831. 
	
 
5-cyanotryptophan (Table 4, entry 4). White solid (33 mg, 49% yield), corresponding to 2450 
turnovers. 1H NMR (500 MHz, D2O) δ 7.92 (dd, J = 1.6, 0.7 Hz, 1H), 7.47 (dd, J = 8.5, 0.7 Hz, 1H), 
7.39 (dd, J = 8.5, 1.5 Hz, 1H), 7.35 (s, 1H), 4.26 (dd, J = 7.0, 5.5 Hz, 1H), 3.37 (ABXY, JAX = 7.0 Hz, 
JAY = 0.7, JBX = 5.5 Hz, JBY = 0.8 Hz, JAB = 15.4 Hz, νAB = 28.0 Hz, 2H). 13C NMR (100 MHz, D2O) 
δ 172.1, 138.3, 127.4, 126.2, 124.8, 124.3, 121.8, 112.7, 107.5, 100.7, 53.4, 25.6. HRMS (FAB) (m/z) for [M+H]+ 
C12H12N3O2 requires 230.0929, observed 230.0928. 
	
 
5-formyltryptophan (Table 4, entry 5). Orange solid (22 mg, 32% yield), corresponding to 1600 
turnovers. 1H NMR (500 MHz, D2O) δ 9.68 (d, J = 0.5 Hz, 1H), 7.98 (dd, J = 1.6, 0.7 Hz, 1H), 7.57 
(dd, J = 8.6, 1.6 Hz, 1H), 7.43 (dt, J = 8.6, 0.6 Hz, 1H), 7.30 (s, 1H), 4.29 (dd, J = 6.9, 5.5 Hz, 1H), 
3.37 (ABXY, JAX = 6.9 Hz, JAY = 0.7, JBX = 5.5 Hz, JBY = 0.7 Hz, JAB = 15.6 Hz, νAB = 24.4 Hz, 2H). 
13C NMR (100 MHz, D2O) δ 13C NMR (101 MHz, D2O) δ 196.2, 172.1, 140.3, 128.0, 127.2, 126.4, 122.2, 112.5, 
108.7, 53.4, 25.6. HRMS (FAB) (m/z) for [M+H]+ C12H13N2O3 requires 233.0926, observed 233.0930. 
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Signal 1: DAD1 A, Sig=330,8 Ref=off
Peak RetTime Type Width Area Height Area
# [min] [min] [mAU*s] [mAU] %
----|-------|----|-------|----------|----------|--------|
1 3.450 BV 0.0602 5759.50977 1395.42200 99.5557
2 3.781 VB 0.0391 25.70636 9.96104 0.4443
Signal 1: DAD1 A, Sig=330,8 Ref=off
Peak RetTime Type Width Area Height Area
# [min] [min] [mAU*s] [mAU] %
----|-------|----|-------|----------|----------|--------|
1 3.490 BB 0.0518 1743.51855 498.75497 43.8009
2 3.753 BV 0.0548 2237.03442 596.36133 56.1991
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Signal 1: DAD1 A, Sig=330,8 Ref=off
Peak RetTime Type Width Area Height Area
# [min] [min] [mAU*s] [mAU] %
----|-------|----|-------|----------|----------|--------|
1 3.236 BV 0.0556 5448.84082 1426.40955 99.4750
2 3.566 VV 0.0422 28.75493 10.11823 0.5250
Signal 1: DAD1 A, Sig=330,8 Ref=off
Peak RetTime Type Width Area Height Area
# [min] [min] [mAU*s] [mAU] %
----|-------|----|-------|----------|----------|--------|
1 3.270 BB 0.0512 2385.70728 691.76343 45.7334
2 3.539 BV 0.0541 2830.85156 765.56097 54.2666
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5-boronotryptophan (Table 4, entry 6). The substrate 5-boronoindole was subjected to the same 
procedure as entries 2–5, but with slight modifications. Due to competing proto-deborylation, the 
reaction mixture was not heated prior to the addition of enzyme. Furthermore, the product was 
sufficiently soluble in water that all extraction steps used neutral water instead of 0.1 M aq. HCl. 
Finally, the higher polarity of the product, as well as the presence of tryptophan as a contaminant, hindered the 
chromatographic purification of the product. Thus, to better assess the yield, the product was partially purified 
chromatographically, as described above, then dissolved in 1000 µL of D2O that contained CH3CN in a 104 µM 
concentration. The solution was analyzed by 1H NMR with a 10-s relaxation time, and the sum of the integrations of 
the signals at 3.93, 3.40, and 3.22 ppm was divided by the integration of the CH3CN signal (2.03 ppm), indicating 
that the concentration of product was 38.4 µM, which indicates a 38% yield and 1900 total turnovers. 
1H NMR (500 MHz, D2O) δ 8.05 (t, J = 1.0 Hz, 1H), 7.55 (dd, J = 8.2, 1.2 Hz, 1H), 7.48 (dd, J = 8.3, 0.8 Hz, 1H), 
7.26 (s, 1H), 3.93 (dd, J = 7.8, 5.0 Hz, 1H), 3.31 (ABX, JAX = 7.8 Hz, JBX = 5.0 Hz, JAB = 15.2 Hz, νAB = 89.25 Hz, 
2H). 13C NMR (100 MHz, D2O) δ 176.1, 160.7, 137.8, 126.9, 126.6, 125.1, 124.5, 111.4, 108.5, 55.3, 27.1. HRMS 
(ESI) (m/z) for [M+H]+ C11H14BN2O4 requires 249.1047, observed 249.1048. 
	
 
5-hydroxytryptophan (Table 4, entry 7). The reaction with this substrate followed the general 
procedure, but with modified post-reaction processing. The reaction was performed with 33.3 mg of 
5-hydroxyindole (250 µM), 1.2 equiv of L-Ser, and 0.01 mol % of enzyme. The starting materials 
were dissolved in 1250 µL DMSO and 23.5 mL of potassium phosphate buffer, for a final reaction 
volume of about 25 mL. The reaction was heated for 2 hours, then cooled in ice. The reaction mixture was subjected 
to the same washing procedure described above, except that water was used in place of 0.1 M aq. HCl. Due to the 
higher polarity of the product, as well as the presence of a contaminant that is presumed to be an oxidative side-
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Signal 1: DAD1 A, Sig=330,4 Ref=off
Peak RetTime Type Width Area Height Area
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----|-------|----|-------|----------|----------|--------|
1 3.005 BB 0.0484 3945.69775 1197.23047 100.0000
Signal 1: DAD1 A, Sig=330,4 Ref=off
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product, the product could not be purified chromatographically. As a result, the material was partially purified by 
chromatography as described above, then dissolved in 1000 µL of D2O that contained CH3CN in a 104 µM 
concentration. The solution was analyzed by 1H NMR with a 10-s relaxation time, and the sum of the integrations of 
the signals at 3.73, 3.20, and 3.01 ppm was divided by the integration of the CH3CN signal (1.98 ppm), indicating 
that the concentration of product was 233 µM, which indicates a 93% yield and 9300 total turnovers. 
1H NMR (500 MHz, D2O) δ 1H NMR (500 MHz, Deuterium Oxide) δ 7.26 (dd, J = 8.7, 0.6 Hz, 1H), 7.12 (s, 1H), 
7.03 (dd, J = 2.5, 0.6 Hz, 1H), 6.75 (ddd, J = 8.7, 2.4, 0.5 Hz, 1H), 3.73 (dd, J = 8.0, 4.8 Hz, 1H), 3.11 (ABXY, JAX 
= 8.0 Hz, JAY = 0.6 Hz, JBX = 4.9 Hz, JBY = 0.8 Hz, JAB = 15.0 Hz, νAB = 93.3 Hz, 2H). 13C NMR (125 MHz, D2O) δ 
177.3, 148.9, 131.4, 127.6, 125.7, 112.7, 111.8, 107.9, 102.8, 55.4, 27.8. HRMS (FAB) (m/z) for [M+H]+ 
C11H13N2O3 requires 221.0926, observed 221.0922. 
* Derivatization with FDNP-alanamide gave two isomeric products, possibly due to competing arylation of the 
phenolic oxygen. 
	
 
Modification for Table 4, entries 8–9. Initially, it was observed that the products of these reactions developed a 
red color during the post-reaction processing. This was accompanied by the appearance of a contaminant that 
possessed the expected mass of the product plus 16 mass units. As a result, the product solutions were subjected to 
one freeze-pump-thaw cycle prior to any concentration in vacuo. This appeared to suppress the decomposition. 
 
5-methyltryptophan (Table 4, entry 8). The reaction was performed with 32.8 mg of 5-methylindole 
(250 µM), 1.2 equiv of L-Ser, and 0.01 mol % of enzyme. The starting materials were dissolved in 
1250 µL DMSO and 23.5 mL of potassium phosphate buffer, for a final reaction volume of about 25 
mL. The reaction was heated for 2 h, then processed as described above to afford 5-methyltryptophan 
hydrochloride as a white solid (58 mg, 91% yield), corresponding to 9100 turnovers.  
1H NMR (500 MHz, D2O) δ 7.44 (s, 1H), 7.39 (d, J = 8.3 Hz, 1H), 7.24 (s, 1H), 7.09 (dd, J = 8.4, 1.6 Hz, 1H), 4.31 
(dd, J = 7.3, 5.2 Hz, 1H), 3.40 (ABX, JAX = 7.4 Hz, JBX = 5.3 Hz, JAB = 15.4 Hz, νAB = 47.4 Hz, 2H), 2.40 (s, 3H). 
13C NMR (125 MHz, D2O) δ 172.1, 134.6, 129.3, 126.8, 125.5, 123.7, 117.6, 111.9, 105.9, 53.4, 25.9, 20.5. HRMS 
(FAB) (m/z) for [M+H]+ C12H15N2O2 requires 219.1134, observed 219.1132. 
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Signal 3: MSD1 473, EIC=472.7:473.7
Peak RetTime Type Width Area Height Area
# [min] [min] %
----|-------|----|-------|----------|----------|--------|
1 2.429 BV 0.0704 3.80469e6 8.66178e5 91.6185
2 2.761 VBA 0.0793 3.48065e5 6.74129e4 8.3815
Signal 3: MSD1 473, EIC=472.7:473.7
Peak RetTime Type Width Area Height Area
# [min] [min] %
----|-------|----|-------|----------|----------|--------|
1 2.439 BV 0.0526 2.43408e6 6.59723e5 44.8812
2 2.493 VV 0.0677 2.56074e6 6.30598e5 47.2168
3 2.776 VB 0.0731 2.18895e5 4.73079e4 4.0361
4 3.021 BBA 0.0732 2.09664e5 4.52556e4 3.8659
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5-methoxytryptophan (Table 4, entry 9). The reaction was performed with 73.6 mg of 5-
methoxyindole (500 µM), 1.2 equiv of L-Ser, and 0.01 mol % of enzyme. The starting materials were 
dissolved in 500 µL DMSO and 8938 µL of potassium phosphate buffer, for a final reaction volume 
of about 10 mL. The reaction was heated for 2 h, then processed as described above to afford 5-
methoxytryptophan hydrochloride as a white solid (103 mg, 76% yield), corresponding to 7600 turnovers. 
1H NMR (500 MHz, D2O) δ 1H NMR (500 MHz, Deuterium Oxide) δ 7.37 (dd, J = 8.9, 0.5 Hz, 1H), 7.23 (s, 1H), 
7.12 (dd, J = 2.5, 0.6 Hz, 1H), 6.86 (ddd, J = 8.9, 2.5, 0.4 Hz, 1H), 4.28 (dd, J = 7.1, 5.3 Hz, 1H), 3.35 (ABXY, JAX 
= 7.2 Hz, JAY = 0.7 Hz, JBX = 5.4 Hz, JBY = 0.8 Hz, JAB = 15.5 Hz, νAB = 34.9 Hz, 2H). 13C NMR (100 MHz, D2O) δ 
172.1, 153.0, 131.7, 126.9, 126.2, 112.9, 111.9, 106.1, 100.5, 56.0, 53.3, 25.7. HRMS (FAB) (m/z) for [M+H]+ 
C12H15N2O3 requires 235.1083, observed 235.1084. 
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Signal 1: DAD1 A, Sig=330,8 Ref=off
Peak RetTime Type Width Area Height Area
# [min] [min] [mAU*s] [mAU] %
----|-------|----|-------|----------|----------|--------|
1 3.876 VV 0.0484 4178.52832 1269.27234 99.4886
2 4.192 BV 0.0321 21.47815 9.97874 0.5114
Signal 1: DAD1 A, Sig=330,8 Ref=off
Peak RetTime Type Width Area Height Area
# [min] [min] [mAU*s] [mAU] %
----|-------|----|-------|----------|----------|--------|
1 3.893 BV 0.0458 2247.41968 733.06561 45.2738
2 4.205 VV 0.0492 2716.64355 808.07471 54.7262
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Signal 1: DAD1 A, Sig=330,8 Ref=off
Peak RetTime Type Width Area Height Area
# [min] [min] [mAU*s] [mAU] %
----|-------|----|-------|----------|----------|--------|
1 3.438 BV 0.0492 4998.42236 1488.41821 99.5761
2 3.735 VV 0.0311 21.27838 10.29514 0.4239
Signal 1: DAD1 A, Sig=330,8 Ref=off
Peak RetTime Type Width Area Height Area
# [min] [min] [mAU*s] [mAU] %
----|-------|----|-------|----------|----------|--------|
1 3.447 BB 0.0463 2631.31177 844.92169 47.0564
2 3.738 BB 0.0486 2960.51782 895.60193 52.9436
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8. 1H and 13C NMR spectra of tryptophan derivatives 
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